Mr Randall brings to Nanosphere’s board of directors extensive senior executive and independent board member experience in the healthcare, manufacturing and technology industries.
Mr Randall has previous experience as the CFO and CEO of medical and technology companies. Most recently, Mr Randall has served as the CFO of Eximias Pharmaceutical and before that as the CFO of i-STAT. Currently, he serves on the boards of several emerging healthcare companies.
Mr Randall received his BS from the Pennsylvania State University and his MBA from Northeastern University.
William Moffitt, president and CEO, said: We are pleased to welcome Jeff to the board and as our audit committee chair. Jeff’s background is well suited to help guide our company as we build the infrastructure needed to deliver on our significant growth opportunities.”